Sinovac to reach two billion vaccine doses annually
BEIJING – China’s Sinovac Biotech conformed its third production plant for its COVID-19 vaccine was ready and had started manufacturing procedures for bulk vaccine ingredient, doubling its annual capacity to 2 billion doses. A Sinovac spokesman said the third facility, … Continue reading Sinovac to reach two billion vaccine doses annually
CureVac: Over 100 Million vaccines to be produced
TÜBINGEN – CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) and Celonic Group, a premium biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the development and production … Continue reading CureVac: Over 100 Million vaccines to be produced
EMA Approves BioNTech Storage Option for EU
NEW YORK/MAINZ – Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Medicines Agency (EMA) approved storage of COMIRNATY® at -25°C to -15°C for a total of two weeks based on data showing the stability at these temperatures in … Continue reading EMA Approves BioNTech Storage Option for EU
Moderna vaccine approved by Singapore Health Authority
CAMBRIDGE, Mass./Singapore -Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Singapore Health Sciences Authority (HSA) has approved the interim authorization of its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use … Continue reading Moderna vaccine approved by Singapore Health Authority
Moderna: Provides 600 million dosis of vaccine
CAMBRIDGE, Mass – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global production estimate from 500 to 600 million doses for 2021. Moderna said it … Continue reading Moderna: Provides 600 million dosis of vaccine
WHO: Beijing welcomes COVID-19 investigations
Geneve – Beijing will welcome an international team of COVID-19 investigators due to travel to China in January, said the World Health Organization (WHO), which is leading the mission. China has strongly opposed calls for an international inquiry into the … Continue reading WHO: Beijing welcomes COVID-19 investigations
Covid-19: Baricitinib plus remdesivir shows promising
Washington – The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the … Continue reading Covid-19: Baricitinib plus remdesivir shows promising
COVID Vaccine: Moderna is conducting a clinical trial
Washington – Moderna has finished accumulating data for a first analysis of its COVID-19 vaccine and expects to have an announcement on the vaccine’s efficacy by the end of the month, the company said in a statement Wednesday. Pfizer announced Monday that … Continue reading COVID Vaccine: Moderna is conducting a clinical trial
COVID-19: NIH begins large clinical trial
Washington – The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which … Continue reading COVID-19: NIH begins large clinical trial
NIH study identifies promising COVID-19 treatments
Washington – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 … Continue reading NIH study identifies promising COVID-19 treatments